Pfam Domains GO Terms
| Homeobox |
| CUT |
| spleen development |
| endocrine pancreas development |
| pancreas development |
| negative regulation of transforming growth factor beta receptor signaling pathway |
| endoderm development |
| negative regulation of cellular response to transforming growth factor beta stimulus |
| B cell differentiation |
| glucose metabolic process |
| regulation of transforming growth factor beta receptor signaling pathway |
| regulation of cell-matrix adhesion |
| negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| regulation of cellular response to transforming growth factor beta stimulus |
| endocrine system development |
| liver development |
| Notch signaling pathway |
| hepaticobiliary system development |
| negative regulation of cellular response to growth factor stimulus |
| B cell activation |
| hexose metabolic process |
| epithelial cell development |
| monosaccharide metabolic process |
| regulation of cell-substrate adhesion |
| regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| lymphocyte differentiation |
| cell fate commitment |
| regulation of cellular response to growth factor stimulus |
| leukocyte differentiation |
| cilium assembly |
| cilium organization |
| lymphocyte activation |
| gland development |
| plasma membrane bounded cell projection assembly |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| cell projection assembly |
| carbohydrate metabolic process |
| positive regulation of cell migration |
| positive regulation of cell motility |
| positive regulation of cellular component movement |
| positive regulation of locomotion |
| hemopoiesis |
| hematopoietic or lymphoid organ development |
| immune system development |
| regulation of cell adhesion |
| epithelial cell differentiation |
| organelle assembly |
| regulation of cell migration |
| regulation of cell motility |
| leukocyte activation |
| regulation of locomotion |
| regulation of cellular component movement |
| cell activation |
| epithelium development |
| plasma membrane bounded cell projection organization |
| cell projection organization |
| positive regulation of transcription by RNA polymerase II |
| negative regulation of signal transduction |
| negative regulation of cell communication |
| negative regulation of signaling |
| DNA binding |
| positive regulation of transcription, DNA-templated |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| negative regulation of response to stimulus |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cell development |
| positive regulation of RNA metabolic process |
| small molecule metabolic process |
| tissue development |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution